Castle Biosciences (CSTL) Prepaid Assets (2018 - 2026)

Castle Biosciences has disclosed Prepaid Assets across 9 years of filings, most recently posting $14.5 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $14.5 million, up 31.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.5 million (up 31.32% YoY), and the FY2025 annual result was $8.0 million, up 3.72% from the prior year.
• Prepaid Assets came in at $14.5 million for Q1 2026 at Castle Biosciences, up from $8.0 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $14.5 million in Q1 2026 to a low of $5.2 million in Q1 2022.
• The 5-year median for Prepaid Assets is $6.8 million (2023), against an average of $8.0 million.
• Across the five-year window, Prepaid Assets declined 8.47% in 2024 and jumped 79.59% in 2025, its largest moves.
• Castle Biosciences' Prepaid Assets stood at $6.2 million in 2022, then climbed by 1.37% to $6.3 million in 2023, then grew by 21.92% to $7.7 million in 2024, then climbed by 3.72% to $8.0 million in 2025, then jumped by 82.14% to $14.5 million in 2026.
• The last three Prepaid Assets figures came in at $14.5 million (Q1 2026), $8.0 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.